The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that, besides mediating toxic responses, may have a central role in ovarian physiology. Studying the actions of AHR ligands on granulosa cells function, we have found that beta-naphthoflavone amplifies the comitogenic actions of FSH and 17beta-estradiol in a dose-dependent manner. This amplification was even greater in cells that overexpress the AHR and was reversed by cotreatment with the AHR antagonist alphanaphthoflavone, suggesting that this effect is mediated by the AHR. The estrogen receptor is likewise implicated in this phenomenon, because a pure antiestrogen abolished the described synergism. However, the more traditional inhibitory AHR-estrogen receptor interaction was observed on the estrogen response element-driven transcriptional activity. On the other hand, alpha-naphthoflavone inhibited dose-dependently the mitogenic actions of FSH and 17beta-estradiol. Betanaphthoflavone induced the expression of Cyp1a1 and Cyp1b1 transcripts, two well-characterized AHR-inducible genes that code for hydroxylases that metabolize estradiol to catecholestrogens. Nevertheless, the positive effect of beta-naphthoflavone on proliferation was not caused by increased metabolism of estradiol to catecholestrogens, because these compounds inhibited the hormonally stimulated DNA synthesis. This latter inhibition exerted by catecholestrogens suggests that these hydroxylases would play a regulatory point in granulosa cell proliferation. Our study indicates that AHR ligands modulate the proliferation of rat granulosa cells, and demonstrates for the first time that an agonist of this receptor is able to amplify the comitogenic action of classical hormones through a mechanism that might implicate a positive cross-talk between the AHR and the estrogen receptor pathways.
INTRODUCTION
The aryl hydrocarbon receptor (AHR) is a ligand-activated basic-helix-loop-helix-PAS (bHLH-PAS) transcription factor that mediates a variety of toxic and biological effects of different classes of aromatic compounds: halogenated aromatics, e.g., 2,3,7,8-tetrachlorodibenzeno-p-dioxin (TCDD); polycylic aromatic hydrocarbons (PAHs), e.g., 3-methylcholanthrene (3-MC); and heteropolynuclear aromatic hydrocarbons, e.g., b-naphthoflavone (5,6-benzophlavone) and anaphthoflavone (7,8-benzophlavone) . This receptor and homologues are widely and ubiquitously expressed in diverse tissues throughout different groups of vertebrates and invertebrates (reviewed in [1, 2] ).
Upon binding agonists, the AHR translocates from the cytoplasm to the nucleus, where it forms a heterodimer with another bHLH-PAS protein known as the aryl hydrocarbon nuclear translocator (ARNT). This heterodimeric complex binds to cognate DNA sequences, known as xenobiotic response elements, and upregulates the transcription of a battery of xenobiotic metabolizing enzymes (XMEs). These regulated XMEs include the cytochrome P450s CYP1A1, CYP1B1, and CYP1A2 and the phase II enzymes GSTA5 and UGT1A1 (reviewed in [3] [4] [5] [6] ).
The environmental contaminant TCDD is the most potent congener among these aromatic compounds and the prototype of these receptor agonists. Its effect and the involvement of the AHR in acute toxicity and teratogenesis have been well studied (reviewed in [7] ). Besides, AHR agonists have been extensively investigated as antiestrogens in the rodent mammary gland and uterus and in human breast cancer cell lines [8] , this effect being complex and related to the inhibitory cross-talk between the AHR and the estrogen receptor [4, [9] [10] [11] . The role of the AHR in carcinogenesis has also been studied and discussed (reviewed in [11] ).
Several reports have shown constitutive activation of the AHR in the absence of an exogenous ligand, suggesting that the AHR may play important roles not only in the regulation of xenobiotic metabolism but also in the maintenance of homeostatic function [12] [13] [14] [15] . It has been demonstrated that the absence of this receptor produces, among other effects, impairment in liver development (reviewed in [7] ), reduced incidence of blastocyst formation, and smaller mean cell number in cultured embryos [16] . In addition, it has been demonstrated that the AHR plays a role in cell cycle regulation in some systems (reviewed in [17] ).
The presence of the AHR has been described in oocytes and granulosa cells in the rat ovarian follicles [18] . Deletion of this receptor produces changes in follicular selection processes, apparently caused by alterations in growth of preantral and antral follicles, and alterations in embryonic implantation in animals lacking this receptor have also been described [19] [20] [21] .
With the aim of studying the possible modulation that the AHR may exert on granulosa cells function, we investigated in the present study the role of AHR ligands on the growth of these cells. The effects of two aromatic hydrocarbons (bnaphthoflavone and a-naphthoflavone) that have been described as agonist and antagonist of this receptor in a variety of systems [22] [23] [24] [25] [26] [27] [28] [29] [30] were tested in a defined culture system of rat granulosa cells that has been extensively characterized in terms of hormonally regulated cell proliferation [31] .
MATERIALS AND METHODS

Hormones and Chemicals
Ovine FSH (NIDDK-oFSH-20) was obtained from the National Hormone and Pituitary Program. Two-hydroxyestradiol and 2-methoxyestradiol were purchased from Steraloids, Inc., ICI 182,780 was purchased from Tocris, and [methyl-
3 H]-thymidine from Dupont NEN Research Products. Tissue culture reagents, 17b-estradiol (estradiol), and all other chemicals were obtained from Sigma Chemical Co., unless otherwise indicated. Collagen was prepared from rat tails as previously described [32] .
Granulosa Cell Preparation and Culture
Ovaries were obtained from 24-to 26-day-old female Sprague-Dawley rats, from the institute colony, after 4 days of diethylstilbestrol (DES) treatment (subcutaneous Silastic implants containing 5 mg DES). The animal procedures were reviewed and approved by the Animal Research Committee of our Institution, which follows the guidelines of the National Institute of Health. Granulosa cells were prepared and cultured as previously described [33] . Briefly, the ovaries were punctured with a 30-gauge needle and incubated in Dulbecco modified Eagle medium (DMEM, 4.5 g glucose/liter)-Ham F12 (1:1; Gibco), EGTA (6.8 mM), and Hepes (10 mM; 15 min at 378C), and then washed and incubated in DMEM-F12 (1:1), sucrose (0.5 M), and Hepes (10 mM; 5 min at 378C). After incubation, the medium was diluted with 2 volumes of DMEM-F12 and Hepes (10 mM), and ovaries were allowed to sediment. Granulosa cells were obtained by pressing ovaries within two pieces of nylon mesh (Nytex 50). To eliminate contaminating theca/interstitial cells, the crude granulosa cell suspension was layered over a 40% Percoll solution in saline, and centrifuged at 400 3 g for 20 min. The purified granulosa cell layer was aspirated from the top of the Percoll solution and resuspended in DMEM-F12 (1:1) containing bicarbonate (2.2 g/L; pH 7.4), unless otherwise indicated. Cells were seeded on plastic plates (Nunc) precoated with collagen. Cells were maintained at 378C with 5% CO 2 . After 2 h, media were changed to remove nonattached cells and were replaced by fresh media containing the different factors to be tested.
DNA Synthesis Assay
DNA synthesis was determined by [ 3 H]-thymidine incorporation according to a method previously validated in these culture conditions [31] [32] [33] [34] . Briefly, granulosa cells were cultured in 96-well plates at an initial plating density of 3 3 10 5 viable cells/cm 2 , in the presence of different hormones and compounds. Tritiated thymidine (4 lCi/ml) was added to the cultures 24 h after plating. Cells were harvested 24 h later in glass hollow fibers with a multiwell cell harvester (Nunc) and radioactivity was measured in a scintillation counter.
Western Blot Analysis
Granulosa cells were cultured in P6 multiwell plates at a density of 2.5 3 10 6 viable cells/well. After 36 h of incubation with the different stimuli, the cells were taken up in lysis buffer and processed for protein extraction. Twenty-five micrograms of total protein were electrophoresed under reducing conditions in 12% polyacrylamide gels and electrotransferred to nitrocellulose membranes. To corroborate equal protein load in each lane, membranes were stained after transfer with Ponceau S. Proliferating cell nuclear antigen (PCNA) and G1/S-specific cyclin D2 (CCND2) expression was assessed with standard Western Blot techniques using an antibody against PCNA raised in mouse (PC10; Santa Cruz Biotechnology, Inc.; diluted 1:5000) or an antibody against CCND2 raised in mouse (M10; Santa Cruz Biotechnology, Inc.; diluted 1:100), respectively, and the appropriate peroxidase-conjugated second antibody (Amersham Biosciences). Detection was performed with a chemioluminiscence kit (DuPont NEN). The assay was performed for three independent experiments, obtaining the same pattern of response in each separate experiment.
Overexpression of AHR in Granulosa Cells and Immunoflorescence for CCND2
Granulosa cells were cultured in a LAB-TEK Chamber Slide (Nalge Nunc International Corp.) at a density of 3 3 Research Center, Inc.) at 0.75 ll liposomes/cm 2 and 500 ng DNA/cm 2 . Twenty-four h posttransfection, media were changed and the different stimuli were added. After 36 h of stimuli, cells were fixed in P-formaldehyde 4% for 10 min. After washing cells with PBS, cells were permeabilized for 30 min in Triton 3100 0.25%, washed afterwards with PBS and blocked for 30 min with 10% goat normal serum-1% BSA in PBS-Tween 20 (0.05%). Incubation with first antibodies against CCND2 (Santa Cruz Biotechnology, Inc.; diluted 1:500) and AHR (Affinity BioReagents; diluted 1:500) was done ON at 48C. Thereafter, cells were washed with PBS and incubated with Cy3-conjugated anti-rabbit IgG and Cy2-conjugated anti-mouse IgG (Jackson ImmunoResearch; BA, diluted 1:100) for 1 h at room temperature. After washing with PBS, samples were allowed to dry and then mounted with Mowiol mounting media. Images were then analyzed by confocal microscopy.
Semiquantitative RT-PCR
Levels of Cyp1a1 and Cyp1b1 mRNA expression in rat granulosa cells were assessed using semiquantitative RT-PCR. Granulosa cells were cultured in P6 multiwell plates at a density of 2.5 3 10 6 viable cells/well. After 24 h (for Cyp1a1) or 6 h (for Cyp1b1) of incubation with the different stimuli, cells were lysed directly in the culture dish with TRIzol Reagent (Invitrogen, Molecular Research Center, Inc.) and total RNA extracted according to the manufacturer's instructions. Complementary DNA was synthesized from deoxyribonuclease Itreated (DNA free, Ambion Inc.) total RNA (1 lg RNA in 10 ll of RT reaction). A blank without RNA was included in each set of RT reactions. A control of RNA that was not subjected to RT was also included in subsequent PCR reactions.
The primer sequences used to amplify the two hydroxylases' target cDNAs were those described by Dasmahapatra et al. [35] . Cyp1a1 and 18S Classic II primers:competimers (Quantum mRNA Ambion, Inc.; used as internal control for normalization) generated fragments of 509 and 324 bp, respectively. Cyp1b1 and 18S Classic primers:competimers (Quantum mRNA Ambion, Inc.) generated fragments of 372 and 488 bp, respectively.
One-microliter aliquots of the RT reaction were used to amplify Cyp1a1 or Cyp1b1 and 18S fragments in a multiplex reaction. In preliminary experiments, optimum cycle number was determined for each target, so that signals were always in the exponential portion of the amplification curve. All amplification programs included an initial step at 948C for 3 min and a final step at 728C for 5 min. Each cycle consisted of 30 sec denaturation at 948C, 30 sec annealing at the temperature indicated in each case, and 1 min extension at 728C. Amplification of Cyp1a1 and 18S Classic II cDNAs was performed for 33 cycles, 2 mM MgCl 2 and annealing at 628C. Cyp1b1 and 18S Classic cDNAs were amplified for 32 cycles in the presence of 2 mM MgCl 2 , annealing at 658C. Ten microliters of the PCR reaction were electrophoresed in 2% agarose gels with subsequent ethidium bromide staining. The relative amount of each mRNA was quantified with ImageQuant software (Amersham Biosciences) and normalized to the 18S ribosomal signal (given by the 18S primers:18S competimers ratio) for each sample.
Estradiol Radioimmunoassay
Granulosa cells were cultured in 96-well plates at a density of 3 3 10 5 viable cells/cm 2 for 64 h, in the presence of different stimuli and androstenedione (0.35 lM) as aromatizable substrate. Estradiol in the culture medium was determined by a specific radioimmunoassay as previously described [36] .
Transient Transfection and Luciferase Assay
Transient transfection of granulosa cells with the reporter construct was performed in suspension by calcium phosphate coprecipitation. Six lg/well of the pTK-Red-ERE-LUC plasmid (kindly given by Dr. M. Beato, Institute for Molecular Biology and Tumor Research, Marburg, Germany) and 6 lg/well of the control reporter plasmid pCMV-b-galactosidase (Clontech) were cotransfected and the cells were then seeded onto P6 multiwell plates at a density of 3 3 10 6 viable cells/well in phenol red-free medium (DMEM-F12 1:1, 2.2 g/L bicarbonate, pH 7.4 without phenol red) with 10% fetal bovine serum (FBS). Nonattached cells were removed 16 h later and phenol red-free fresh medium without FBS was added. Two hours later, fresh phenol red-free medium without FBS containing the different stimuli was added. The incubation was allowed to proceed for 24 h. Cells were then washed twice with PBS and lysed in 200 ll of 13 reporter lysis buffer (Promega) , and the cleared extract was assayed for luciferase and b-galactosidase activities according to the manufacturer's instructions (Promega). Transfection efficiencies were normalized by b-galactosidase activity in each well, and luciferase activity expressed as relative light units, as percentage of the activity observed in the vehicle (ethanol) controls, which was set arbitrarily to 100%. 
Statistical Analysis
Treatments were applied to at least duplicate wells in each of three or four separate experiments, unless otherwise indicated. Results are expressed as the mean 6 SEM of the independent experiments. Statistical comparisons of the results were made using one-way ANOVA and the Tukey-Kramer test for multiple comparisons after logarithmic transformation of data when necessary [37] .
RESULTS
b-Naphthoflavone Amplifies the Comitogenic Effect of FSH and Estradiol in Granulosa Cells
The effect of the well-characterized AHR agonist bnaphthoflavone was assessed on the proliferation of cultured granulosa cells.
No effect was observed on DNA synthesis when this flavone was added either alone or in the presence of FSH (2 ng/ ml), even at the maximal dose tested (Fig. 1A) . However, when b-naphthoflavone was added in the presence of FSH and estradiol (100 ng/ml), it was capable of amplifying the stimulation elicited by both hormones in a dose-dependent manner, having a significant effect at doses of 10 lM or greater (Fig. 1A) . At a dose of 20 lM, this flavone produced a 2.7-fold increase in thymidine incorporation levels when compared to cells treated with a combination of FSH and estradiol.
Thymidine incorporation data were validated by assessing the levels of expression of a marker of proliferating cells, PCNA. As shown in Figure 1B Because CCND2 is the limiting cyclin for the proliferation of granulosa cells and because FSH and estradiol have a synergistic effect on the expression of this cyclin [38, 39] , we assessed the effect of b-naphthoflavone on this protein as well. This flavone added together with FSH and estradiol was able to further increase the expression of CCND2, when compared with the level of expression in cells treated only with both hormones (Fig. 1B, lower panel) .
To determine whether the mitogenic actions of b-naphthoflavone in the presence of FSH and estradiol can also be induced by other AHR agonist, we tested the effect of the receptor agonist 3-MC on granulosa cells' DNA synthesis. As shown in Figure 2 , 3-MC is also able to amplify the proliferative response elicited by FSH and estradiol, as assessed by uptake of tritiated thymidine.
a-Naphthoflavone Inhibits the Comitogenic Effect of FSH and Estradiol in Granulosa Cells
We then examined the effect of a-naphthoflavone (doses ranging from 1 to 20 lM), alone, in combination with FSH, or in combination with FSH and estradiol on granulosa cells proliferation. As shown in Figure 3A , this AHR ligand had no effect on granulosa cells proliferation when added alone or with FSH, but was able to inhibit in a dose dependent fashion (at doses of 5 lM or greater) the proliferative effect of FSH and estradiol. At the maximal dose tested, it was able to produce a 2.6-fold decrease in the estradiol induced DNA synthesis.
Thymidine incorporation data were validated by assessing the levels of expression of a marker of proliferating cells, PCNA. As shown in Figure 3B (upper panel), the expression of PCNA diminishes in cells treated with a-naphthoflavone, FSH and estradiol, when compared with cells treated only with both hormones. Moreover, a-naphthoflavone added together with FSH and estradiol was able to abolish the stimulation of CCND2 expression exerted by these hormones (Fig. 3B, lower panel) .
Specificity of the Comitogenic Action of Estradiol and b-Naphthoflavone
We then tried to determine whether the described synergism observed between estradiol and b-naphthoflavone in the presence of FSH is in fact mediated by the estrogen receptor and the AHR. With this purpose, we decided to test the effect of the antiestrogen ICI 182,780 and the AHR antagonist anaphthoflavone on this system.
As can be seen in Figure 4A , the estrogen receptor antagonist was able to inhibit the synergistic action of estradiol and b-naphthoflavone.
When cells were cotreated with b-naphthoflavone (20 lM) and a-naphthoflavone (10 lM) in the presence of FSH and estradiol, the comitogenic effect of the former flavone was completely suppressed (Fig. 4B) . In the same way, anaphthoflavone at doses of 1 lM was able to reverse the effect of b-naphthoflavone at doses of 10 lM (Fig. 4B) . Thus, b-naphthoflavone is not able to exert its comitogenic effect in the presence of a-naphthoflavone.
Overexpression of AHR Leads to an Increase in b-Naphthoflavone Action on Granulosa Cells Proliferation
With the aim of further studying the involvement of the AHR in the mitogenic action exerted by b-naphthoflavone in the presence of FSH and estradiol, we assessed the effect of this flavone on the proliferation of granulosa cells that overexpress the AHR. As can be seen in Figure 5 , cells that overexpress the AHR have higher levels of CCND2 expression when treated with FSH, estradiol, and b-naphthoflavone than 
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those treated with both hormones and the flavone but having only the endogenous levels of AHR. These results were obtained when assessing the level of CCND2 both by immunofluorescence (Fig. 5A ) and by immunoblotting analyses (Fig. 5B) .
Induction of Cyp1a1 and Cyp1b1 mRNA Levels by b-Naphthoflavone
Because the induction of Cyp1a1 mRNA is one of the described effects of AHR agonists and a typical characteristic of AH-responsiveness in most cells, we decided to evaluate the effect of b-naphthoflavone on these transcripts levels in rat granulosa cells. As shown in Figure 6A , addition of bnaphthoflavone (10 lM) induced Cyp1a1 mRNA ;4.5 fold, as measured by semiquantitative RT-PCR. This effect was abolished by cotreatment with a-naphthoflavone at doses of 0.5 lM, and partially reversed by a-naphthoflavone at doses of 1 lM. Addition of a-naphthoflavone alone, at doses of 0.5 lM, had no effect on the induction of Cyp1a1 mRNA expression, and doses of 1 lM of this flavone produced a modest and marginally significant increase in this hydroxylase mRNA level (Fig. 6A) .
The ability of b-naphthoflavone to induce Cyp1a1 mRNA and the antagonistic effect of a-naphthoflavone on this induction were also verified in the presence of FSH (Fig.  6B) . Besides, b-naphthoflavone was also able to cause an increase in Cyp1b1 mRNA when compared with the basal levels of these transcripts (Fig. 6C) . However, this induction was not as marked as that for Cyp1a1. The addition of estradiol had no effect on the b-naphthoflavone-induced mRNA levels (Fig. 6, B and C) . It is to be noted that basal levels of Cyp1a1 mRNA in untreated granulosa cells were much lower than those for Cyp1b1 (Fig. 6D) .
Effect of the AHR Ligands on Estradiol Production
To elucidate whether the described effects of the AHR ligands b-naphthoflavone and a-naphthoflavone on granulosa cells' DNA synthesis were a result of changes in estradiol levels caused by these compounds, we assessed the levels of this estrogen in granulosa cells treated with the different stimuli.
As shown in Figure 7 , b-naphthoflavone did not significantly alter endogenous estradiol levels, even at doses of 20 lM. In contrast, a-naphthoflavone produced a dose-dependent decrease in estradiol levels, this effect being significant at concentrations of 10 lM or greater (Fig. 7) .
Effect of Catecholestrogens on Granulosa Cells DNA Synthesis
Given the fact that the AHR regulates at the transcriptional level the enzymes CYP1A1 and CYP1B1, which hydroxylate estradiol to give catecholestrogens, we assessed the effect of the catecholestrogens 2-hydroxyestradiol and 2-methoxyestradiol on DNA synthesis in cultured granulosa cells.
As shown in Figure 8 , neither of the tested catecholestrogens was able to amplify the signal of FSH and stimulate the DNA synthesis of these cells. Furthermore, doses of 100 ng/ml or greater of 2-methoxyestradiol and doses of 1 lg/ml of 2-hydroxyestradiol produced an inhibition of DNA synthesis when compared with FSH-treated cultures (Fig. 8) . The addition of the catecholestrogen 4-hydroxyestradiol had no effect, even at the maximal doses tested (data not shown). , 10 lM) or a-naphthoflavone at doses of 0.5 lM (aNF 0.5uM ) or 1 lM (aNF 1uM ), or with a combination of both flavones. Total RNA extraction and semiquantitative RT-PCR for Cyp1a1 mRNA were performed as described in Materials in Methods. The amount of each mRNA was normalized to the 18S ribosomal signal for each sample, and values (relative to control cells) were plotted as the mean 6 SEM of seven independent experiments. Values not sharing a common letter are significantly different (P , 0.001, except for the following comparisons: C vs. aNF 1uM , P , 0.05; aNF 0.5uM vs. bNFþaNF 1uM , P , 0.05; C vs. bNFþaNF 1uM , P , 0.01). B) Granulosa cells were cultured for 24 h in control medium containing 2 ng/ml FSH (F) or treated with b-naphthoflavone (10 lM, FþbNF), with a-naphthoflavone (1 lM, FþaNF), with a combination of both flavones (FþbNFþaNF), or with b-naphthoflavone and E 2 (100 ng/ml, FþbNFþE2). Total RNA extraction and semiquantitative RT-PCR for Cyp1a1 mRNA were performed as described in Materials and Methods. The amount of each mRNA was normalized to the 18S ribosomal signal for each sample, and values (relative to control cells) were plotted as the mean 6 SEM of seven independent experiments. Values not sharing a common letter are significantly different (P , 0.001, except a vs. c, P , 0.05). C) Granulosa cells were cultured for 6 h in control medium containing 2 ng/ml FSH in the absence (F) or presence of b-naphthoflavone alone (10 lM, FþbNF) or in combination with E 2 (100 ng/ml, bNFþE2). Total RNA extraction and semiquantitative RT-PCR for Cyp1b1 mRNA were performed as described in Materials and Methods. The amount of each mRNA was normalized to the 18S ribosomal signal for each sample, and values (relative to control cells) were plotted as the mean 6 SEM of seven independent experiments. Values not sharing a common letter are significantly different (P , 0.001). D) Quantification of Cyp1a1 and Cyp1b1 mRNA signals in samples run in parallel in the same experiment and each normalized to its corresponding 18S signal are depicted as the mean 6 SEM of seven independent experiments. *P , 0.05 vs. same treatment in the other group; **P , 0.01 vs. same treatment in the other group.
b-Naphthoflavone Inhibits the Estrogen Receptor-Mediated Transcriptional Activation
The observed synergism between an AHR agonist and estradiol on the stimulation of DNA synthesis seemed to be in contrast with the antiestrogenic effect of AHR ligands at the genomic level reported in other cell types [4, [9] [10] [11] . Therefore, we decided to investigate whether this negative interaction at the genomic level also takes place in rat granulosa cells. With this aim, we transiently transfected these cells with the pTKRed-ERE-LUC construct, an estradiol-responsive promoter that bears the luciferase gene cloned downstream, and treated the cells with the different stimuli.
As expected, estradiol in the presence of FSH produced a stimulation of 1.5-fold in luciferase activity, which was blocked by cotreatment with ICI 182,780 (Fig. 9) . The addition of b-naphthoflavone to the cultured granulosa cells produced a dramatic inhibition of estradiol-induced luciferase expression (Fig. 9) , reaching levels even lower than those observed in control cells.
DISCUSSION
The AHR is a transcriptionally regulatory protein that binds upstream DNA response elements in target genes involved in xenobiotic metabolism and cellular proliferation and differentiation (reviewed in [3] [4] [5] [6] 17] ). The AHR has been described in the ovary of different species, including the rat, in which the receptor was localized to oocytes, granulosa and thecal cells of growing follicles [40] . Although several lines of evidence indicate that the AHR is implicated in ovarian function, its physiological role has not been clearly established.
The fact that AHR ligands induce destruction of the oocyte, together with the observed increase in primordial oocytes in AHR-null versus wild-type females, has led to the assumption that still unknown ligands of the AHR seem to regulate germ cell death during female gametogenesis [18] . A functional role of the AHR in granulosa cells is also suggested by the finding of a marked induction of its expression after gonadotropin treatment in monkeys [41] .
On the other hand, activation of the AHR by binding of ligands such as the environmental contaminants furans, polyhalogenated dioxins, and polychlorinated biphenyls is associated with a wide range of adverse biological actions [21] .
In the present study we have shown a dose-dependent stimulatory effect of an AHR agonist on rat granulosa cell proliferation that was evidenced only in the presence of estrogens. Although the AHR agonist increased the steady-state levels of Cyp1a1 and Cyp1b1 mRNAs, the described action of this compound was not a result of changes in estradiol endogenous levels caused by increased metabolism, because the radioimmunoassay for this estrogen showed that bnaphthoflavone has no effect on estradiol levels in granulosa cells. Moreover, we have found that the tested catecholestrogens inhibited the hormonally-stimulated DNA synthesis, which rules out the possibility that b-naphthoflavone exerts its action on proliferation through the induction of estradiol metabolism to catecholestrogens. The inhibitory action of 2-hydroxyestradiol and 2-methoxyestradiol on rat granulosa cell proliferation is consistent with similar actions in pig granulosa cells [42] , and suggests that the regulation of CYPs enzyme levels by AHR would be an important regulatory point in granulosa cells growth.
On the other hand, we found that a-naphthoflavone markedly decreases endogenous estradiol levels. This action is consistent with its previously demonstrated inhibition of the aromatase activity in other species [43] [44] [45] , but does not explain the inhibitory action of this flavone on the stimulation of DNA synthesis elicited by exogenous estradiol in our experimental conditions. a-naphthoflavone inhibits hormonally-stimulated proliferation at doses at which it functions as a weak AHR agonist, as assessed by induction of Cyp1a1 mRNA levels. A possible explanation for this apparent contradictory result, when compared to the actions exerted by b-naphthoflavone or 3-MC on proliferation, is that different AHR agonists can lead to complete different patterns of response even in the same cell type, as demonstrated for the induction of apoptosis by PAH-but not dioxin-activated AHR in murine oocytes [46] . Besides, it has to be taken into consideration that despite the partial induction of Cyp1a1 transcripts levels elicited by a-naphthoflavone when present alone at high doses, this flavone acts as an AHR antagonist at those doses in the presence of the AHR agonist b-naphthoflavone in the same experiments. Thus, our results point out that the proliferative response induced by the AHR ligands and estrogen in rat granulosa cells cannot be solely explained by the transcriptional activity of the cognate receptors.
The abrogation of the effect of b-naphthoflavone in the presence of the AHR antagonist a-naphthoflavone, together with the observation that overexpression of the AHR in granulosa cells leads to an increase in b-naphthoflavone amplification of estradiol-stimulated proliferation, strongly suggest that the AHR is implicated in the observed synergism between this flavone and estradiol. The antagonist a-naphthoflavone has been previously shown to counteract the action of other AHR agonists. For example, in vivo treatment with this compound has been shown to prevent the oocyte and primordial follicle destruction induced by 7,12-dimethyl benzanthracene [47] . We postulate that the estrogen receptor is also comprised in this synergism, because the estrogen receptor antagonist ICI 182,780 was also able to abolish the comitogenic effect of estradiol and b-naphthoflavone.
In spite of the amplification of estradiol effects on cell proliferation exerted by the AHR agonist b-naphthoflavone, a negative interaction between both ligands was observed in the expression of a reporter gene under control of a promoter containing an estrogen response element, suggesting a negative interaction between the two receptors at the transcriptional level. Interestingly, this negative phenomenon is not bidirectional, because estradiol did not exert any inhibitory effect on the b-naphthoflavone-stimulated expression of the Cyp1a1 or Cyp1b1 genes. This unidirectional effect is in agreement with findings in fish hepatocytes and in some cell lines [48] [49] [50] , but contrasts with reports in other human and mouse cell lines, where estradiol either decreases or enhances TCDD-induced Cyp1a1 mRNA levels. Thus, the mutual interaction at the transcriptional level appears to be cell-type specific and is most likely regulated by specific protein factors (coactivators or corepressors) restricted to each cell type. Functional and physical interactions between the AHR and the estrogen receptor have been demonstrated in different systems. For example, in MCF-7 cells expressing the AHR, activated AHR inhibits the estrogen receptor mediated responses (reviewed in [51, 52] ) and estradiol exerts transrepression of dioxin-inducible gene transcription through estrogen receptor-AHR-ARNT protein-protein interactions [53] .
Although a positive interaction between both receptors taking place in the promoter of a key gene regulating cell proliferation in granulosa cells cannot be ruled out, our present hypothesis is that the interaction between the estrogen receptor and the AHR does not occur at the transcriptional level. In fact, the negative interaction between both ligands on the pTK-Red-ERE-LUC reporter assay suggests an alternative (probably nongenomic) mechanism underlying the synergism observed on proliferation. In this regard, increasing amounts of evidence indicate that the mitogenic actions of estrogens are exerted through a nongenomic pathway (reviewed in [54] ). It has been reported that the association of agonist activated AHR/ARNT heterodimer with the estrogen receptor results in the recruitment of the unoccupied estrogen receptor and coactivator p300 to estrogen-responsive gene promoters, leading to activation of transcription and estrogenic effects [55] . Our results with the pTK-Red-ERE-LUC reporter assay, the absence of effect of estradiol on the induction of Cyp1a1 and Cyp1b1 mRNA elicited by b-naphthoflavone, and the fact that the effect of this flavone on proliferation occurs only in the presence of estradiol, suggest that the above mentioned mechanism is not responsible for the synergism observed between both ligands in our system. The identity of the AHR endogenous ligand has not been determined. Although tryptophan metabolites [56] [57] [58] and the arachidonic acid metabolite lipoxin [59] have been proposed as candidates, the AHR remains an orphan receptor. In this context, a number of studies have reported that AHR-mediated processes occur in the absence of exogenous AHR ligands and suggested a physiological role for this receptor [14, [60] [61] [62] [63] [64] . In regard to the hydroxylase CYP1A1, it has been found that its expression is developmentally regulated in porcine ovarian granulosa cells [65] and in the fertilized ovum of the mouse [66] . This has led to the hypothesis that this enzyme, regulated at the transcriptional level by the AHR, may be involved in the inactivation of the endogenous ligand. Moreover, constitutive expression of this enzyme and its induction during maturation has been reported in bovine cumulus-oocyte complexes [67] . In our system of cultured rat granulosa cells, the high constitutive levels of Cyp1b1 mRNA, together with the fact that AHR signal was found in the nucleus of untreated cells by immunofluorescence (unpublished data from our laboratory), might indicate the presence of an endogenous ligand for this receptor.
In conclusion, the results of this study provide the first demonstration of a synergism between estradiol and an agonist of the AHR in rat granulosa cell proliferation. Although our data strongly suggest that the AHR and the estrogen receptor are implicated in this effect, the level at which the cross-talk between 424 both pathways takes place remains to be established. Even though most of the reported interactions between both pathways are inhibitory (reviewed in [8, 51] ), still undescribed mechanisms might account for the positive interaction between both occupied receptors reported herein. It is reasonable to speculate that the mitogen-activated protein kinases cascade is also implicated in the observed comitogenic effect of b-naphthoflavone and estradiol, because interactions between the AHR and the mitogen-activated protein kinase signaling pathways (reviewed in [17, 68] ) and between the latter and the estrogen receptor pathway (reviewed in [53] ) have been described.
The effects of the AHR agonist reported herein might reflect the enhanced physiological function of the AHR, the specific actions that environmental contaminants can exert through the xenobiotic-AHR complex, or a combination of both.
Our study suggests that, in addition to the previously proposed action in ovarian physiology, the AHR is involved in the regulation of granulosa cell proliferation through modulation of the mitogenic action of classical hormones.
